TEL
+ 86-21-6420 0566
Краткое описание:
Код каталога 80071739CAS NO.84680-54-6Чистота 98%Номер MDLMFCD00941393EINEC278-459-3Molecular formula C18H24N2O5.2H2OМолекулярн...
Код каталога 80071739
CAS NO.84680-54-6
Чистота 98%
Номер MDLMFCD00941393
EINEC278-459-3
Molecular formula C18H24N2O5.2H2O
Молекулярный вес 384.426
Температура плавления: 151-159 ° C
Аспект | Подробнее |
Главная Информация | Enalaprilat dihydrate is a key pharmaceutical compound. Its chemical formula is C₂₀H₂₈N₂O₇·2H₂O. It is the active metabolite of enalapril, which is a prodrug. Enalaprilat dihydrate exists as a white to off – white powder. It is sparingly soluble in water, but its solubility can be adjusted in pharmaceutical formulations for proper delivery. |
Фармакологическое действие | It belongs to the class of angiotensin – converting enzyme (ACE) inhibitors. By inhibiting ACE, it blocks the conversion of angiotensin I to angiotensin II. This leads to vasodilation as angiotensin II is a potent vasoconstrictor. Additionally, it reduces aldosterone secretion, which helps in decreasing sodium and water reabsorption, thus lowering blood volume and further contributing to blood pressure reduction. |
Клинические применения | Mainly used in the treatment of hypertension. It can be administered intravenously in cases where rapid blood pressure control is required, such as in hypertensive emergencies. It is also beneficial for patients with heart failure, as it improves cardiac function by reducing the afterload on the heart. |
Неблагоприятные реакции | Common side effects may include cough, which is thought to be due to the accumulation of bradykinin as a result of ACE inhibition. Hypotension can occur, especially in patients who are volume – depleted or taking other blood – pressure – lowering medications. Hyperkalemia may also be observed as the reduced aldosterone levels affect potassium excretion. |
Меры предосторожности | Patients with renal impairment need close monitoring as enalaprilat dihydrate can affect kidney function. Pregnant women should avoid using it as it may cause harm to the fetus. It is important to inform healthcare providers about all existing medications to prevent potential drug – drug interactions. |
Отказ от ответственности: приведенный выше контент предназначен только для справки и общения среди инсайдеров отрасли и не гарантирует его точность или полноту. Согласно соответствующим законам и правилам, а также правилам этого веб-сайта, подразделения или лица, которые покупают соответствующие товары, должны получить действительные квалификации и условия квалификации.